SHANGHAI : A year-long slump in China's healthcare stocks has accelerated this week as an anti-corruption campaign gathers pace, threatening the sales of some drug makers and medical equipment producers.
Ten government bodies including the National Health Commission and the Ministry of Public Security kicked off a year-long anti-corruption campaign in the medical system in late July. "The crackdown on corruption would have an obvious impact on drug sales, at least in the short term," he said, adding that pharmaceutical firms with unique or highly competitive products were less vulnerable.
China has cracked down on other sectors in the past, including tutoring, fintech, and property, wiping out trillions of dollars in the companies' market value.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: ChannelNewsAsia - 🏆 6. / 66 続きを読む »
ソース: ChannelNewsAsia - 🏆 6. / 66 続きを読む »